SEARCH

SEARCH BY CITATION

References

  • 1
    Kotloff KL, Winickoff, JP, Ivanoff, B, Clemens, JD, Swerdlow, DL, Sansonetti, PJ, Adak, GK, Levine, MM ( 1999) Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Org 77: 651666.
  • 2
    Schroeder GN, Hilbi H ( 2008) Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion. Clin Microbiol Rev 21: 134156.
  • 3
    Epler CR, Dickenson, NE, Bullitt E, Picking WL ( 2012) Ultrastructural analysis of IpaD at the tip of the nascent MxiH type III secretion apparatus of Shigella flexneri. J Mol Biol 420: 2939.
  • 4
    Barta ML, Guragain M, Adam P, Dickenson NE, Patil M, Geisbrecht BV, Picking WL, Picking WD ( 2012) Identification of the bile salt binding site on IpaD from Shigella flexneri and the influence of ligand binding on IpaD structure. Proteins 80: 935945.
  • 5
    Epler CR, Dickenson NE, Olive AJ, Picking WL, Picking WD ( 2009) Liposomes recruit IpaC to the Shigella flexneri type III secretion apparatus needle as a final step in secretion induction. Infect Immun 77: 27542761.
  • 6
    Martinez-Becerra FJ, Kissmann JM, Diaz-McNair J, Choudhari SP, Quick AM, Mellado-Sanchez G, Clements JD, Pasetti MF, Picking WL ( 2012) Broadly protective Shigella vaccine based on type III secretion apparatus proteins. Infect Immun 80: 12221231.
  • 7
    Markham AP, Birket SE, Picking WD, Picking WL, Middaugh CR ( 2008) pH sensitivity of type III secretion system tip proteins. Proteins 71: 18301842.
  • 8
    Birket SE, Harrington AT, Espina M, Smith ND, Terry CM, Darboe N, Markham AP, Middaugh CR, Picking WL, Picking WD ( 2007) Preparation and characterization of translocator/chaperone complexes and their component proteins from Shigella flexneri. Biochemistry 46: 81288137.
  • 9
    Adam PR, Patil MK, Dickenson NE, Choudhari S, Barta M, Geisbrecht BV, Picking WL, Picking WD ( 2012) Binding affects the tertiary and quaternary structures of the Shigella translocator protein IpaB and its chaperone IpgC. Biochemistry 51: 40624071.
  • 10
    Dickenson NE, Choudhari SP, Adam PR, Kramer RM, Joshi SB, Middaugh CR, Picking WL, Picking WD ( 2013) Oligomeric states of the Shigella translocator protein IpaB provide structural insights into formation of the type III secretion translocon. Protein Science in press.
  • 11
    Barta ML, Zhang L, Picking WL, Geisbrecht BV ( 2010) Evidence for alternative quaternary structure in a bacterial type III secretion system chaperone. BMC Struct Biol 10: 21.
  • 12
    Barta ML, Dickenson NE, Patil M, Keightley JA, Picking WD, Picking WL, Geisbrecht BV ( 2012) The structures of coiled-coil domain from type three secretion system first translocator proteins reveal homology to pore-forming toxins. J Mol Biol 417: 395405.
  • 13
    Maddux NR, Rosen IT, Hu L, Olsen CM, Volkin DB, Middaugh CR ( 2012) An improved methodology for multidimensional high-throughput preformulation characterization of protein conformational stability. J Pharm Sci 101: 20172024.